SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-19-004842
Filing Date
2019-03-13
Accepted
2019-03-13 14:39:03
Documents
1
Group Members
CHARLES SERMONDENISE SCOTS-KNIGHT, PH.D.DR. ALASTAIR MCKINNONPHASE4 VENTURES III GENERAL PARTNER LTDPHASE4 VENTURES III GP LPPHASE4 VENTURES III LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A formsc13da.htm SC 13D/A 367758
  Complete submission text file 0001140361-19-004842.txt   369634
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Subject) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83386 | Film No.: 19678019
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ
Business Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ 44 0 20 3036 0050
Phase4 Partners Ltd (Filed by) CIK: 0001600023 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A